2017 Summit Speakers
Keynote address by Albert Starr, M.D., Lasker Award Winner
Albert Starr, M.D., is a pioneering cardiovascular surgeon who co-invented and successfully implanted the world’s first artificial heart valve. The groundbreaking Starr-Edwards heart valve has saved and prolonged the lives of hundreds of thousands of people around the world. Starr resides in Portland, Oregon, and is a distinguished professor of cardiovascular medicine and chairman of the OHSU Knight Cardiovascular Institute at Oregon Health & Science University.
Christie Ballantyne, M.D.
PCSK9 inhibition: promise fulfilled?
Friday, Sept. 8 | 10:20 a.m.
Dr. Ballantyne is a professor of medicine and chief of cardiology and cardiovascular research at Baylor College of Medicine. He is also director of the Center for Cardiovascular Disease Prevention at Houston Methodist DeBakey Heart & Vascular Center.
Christie Ballantyne is one of the nation’s foremost experts on cholesterol, statins and heart disease prevention. His research interest in the prevention of heart disease has led him to become an established investigator for the American Heart Association. Additionally, he has several National Institutes of Health (NIH) grants to study leukocyte-endothelial adhesion molecules and novel markers for atherosclerosis.
Over the past 34 years, his many accomplishments have included being honored as fellow of the American Association for the Advancement of Science, the American College of Cardiology and the American College of Physicians. In 2014, Thomson Reuters also recognized Christie as one of “The World’s Most Influential Scientific Minds.”
With over 600 publications in the area of atherosclerosis, lipids and inflammation, Christie also serves as an editorial director for www.lipidsonline.org as well as associate editor for Circulation and the Journal of Cardiovascular Risk.
Christie received his M.D. from Baylor College of Medicine and performed both his internal medicine residency and postgraduate training at The University of Texas Southwestern Medical School. He completed a cardiology fellowship at Baylor College of Medicine and an American Heart Association/Bugher Foundation Fellowship at the Howard Hughes Medical Institute and Institute for Molecular Genetics at Baylor.See More
Michael Blaha, M.D., M.P.H.
Providing evidence for subclinical atherosclerosis in risk assessment
Friday, Sept. 8 | 11 a.m.
Dr. Michael J. Blaha currently serves as the director of clinical research for the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. He is an associate editor for the journal Atherosclerosis, associate editor for the Diabetes and Cardiometabolic Clinical Community on acc.org, and is a standing member of the Endocrinologic and Metabolic Drug Advisory Committee (EMDAC) for the FDA.
He has participated in advisory boards for many leading pharmaceutical companies in the cardiometabolic space. He serves on both the Statistics Committee and the Early Career Committee for the American Heart Association (AHA), as well as the Publications and Presentations Committee for the Multi-Ethnic Study of Atherosclerosis (MESA). He is co-chair of the Cross Cohort Collaboration, which seeks to combine data from all ongoing prospective epidemiologic cohorts.
In 2010, Dr. Blaha was given a Young Investigator Award from MESA for work published in The Lancet. In 2013, he was given a second Young Investigator Award from MESA for work published in the European Heart Journal. Dr. Blaha’s work in MESA has been published in such journals as Circulation, Journal of the American College of Cardiology, JAMA, American Journal of Epidemiology, JACC Cardiovascular Imaging, and Atherosclerosis, among others.
He has received multiple grant awards from the National Institutes of Health, Food and Drug Administration, American Heart Association, Amgen, and the Aetna Foundation.
Dr. Blaha has published over 250 original papers and has published two books on the metabolic syndrome. He has mentored over 20 trainees and has delivered grand rounds lectures at over 10 institutions. Dr. Blaha is a founding member of The FIT Project, is a principal investigator of the Coronary Artery Calcium Consortium and is co-director of the mobile health mActive Program at Johns Hopkins.
Clinically, he practices as a preventive noninvasive cardiologist and in the interpretation of cardiac CT.See More